Synthesis of new thiophene and benzo[b]thiophene hydrazide derivatives as human NPY Y(5) antagonists. 2004

Silvia Galiano, and Oihana Erviti, and Silvia Pérez, and Antonio Moreno, and Laura Juanenea, and Ignacio Aldana, and Antonio Monge
Unidad en Investigación y Desarrollo de Medicamentos, Centro de Investigación en Farmacobiología Aplicada (CIFA), Universidad de Navarra, c/Irunlarrea s/n, 31080 Pamplona, Spain.

Neuropeptide Y is one of the most potent appetite stimulating hormones known. Novel thiophene and benzo[b]thiophene hydrazide derivatives were synthetized and evaluated biologically as NPY Y(1) and Y(5) receptor subtype antagonists. They were found to have nanomolar binding affinities for human NPY Y(5) receptor, obtaining the lead compound, trans-N-4-[N'-(thiophene-2-carbonyl)hydrazinocarbonyl]cyclohexylmethyl-4-bromobenzenesulfonamide, which binds with a 7.70 nM IC(50) to the hY(5) receptor.

UI MeSH Term Description Entries
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013876 Thiophenes A monocyclic heteroarene furan in which the oxygen atom is replaced by a sulfur. Thiophene
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D017476 Receptors, Neuropeptide Y Cell surface proteins that bind neuropeptide Y with high affinity and trigger intracellular changes which influence the behavior of cells. Neuropeptide Y Receptors,Neuropeptide Y Receptor,Receptor, Neuropeptide Y
D019556 COS Cells CELL LINES derived from the CV-1 cell line by transformation with a replication origin defective mutant of SV40 VIRUS, which codes for wild type large T antigen (ANTIGENS, POLYOMAVIRUS TRANSFORMING). They are used for transfection and cloning. (The CV-1 cell line was derived from the kidney of an adult male African green monkey (CHLOROCEBUS AETHIOPS).) COS-1 Cells,COS-7 Cells,COS 1 Cells,COS 7 Cells,COS Cell,COS-1 Cell,COS-7 Cell,Cell, COS,Cell, COS-1,Cell, COS-7,Cells, COS,Cells, COS-1,Cells, COS-7

Related Publications

Silvia Galiano, and Oihana Erviti, and Silvia Pérez, and Antonio Moreno, and Laura Juanenea, and Ignacio Aldana, and Antonio Monge
October 2016, Bioorganic & medicinal chemistry letters,
Silvia Galiano, and Oihana Erviti, and Silvia Pérez, and Antonio Moreno, and Laura Juanenea, and Ignacio Aldana, and Antonio Monge
February 2010, European journal of medicinal chemistry,
Silvia Galiano, and Oihana Erviti, and Silvia Pérez, and Antonio Moreno, and Laura Juanenea, and Ignacio Aldana, and Antonio Monge
October 2009, Bioorganic & medicinal chemistry,
Silvia Galiano, and Oihana Erviti, and Silvia Pérez, and Antonio Moreno, and Laura Juanenea, and Ignacio Aldana, and Antonio Monge
November 1966, Journal of medicinal chemistry,
Silvia Galiano, and Oihana Erviti, and Silvia Pérez, and Antonio Moreno, and Laura Juanenea, and Ignacio Aldana, and Antonio Monge
March 2006, Bioorganic & medicinal chemistry letters,
Silvia Galiano, and Oihana Erviti, and Silvia Pérez, and Antonio Moreno, and Laura Juanenea, and Ignacio Aldana, and Antonio Monge
January 1970, Advances in drug research,
Silvia Galiano, and Oihana Erviti, and Silvia Pérez, and Antonio Moreno, and Laura Juanenea, and Ignacio Aldana, and Antonio Monge
July 1966, Journal of medicinal chemistry,
Silvia Galiano, and Oihana Erviti, and Silvia Pérez, and Antonio Moreno, and Laura Juanenea, and Ignacio Aldana, and Antonio Monge
January 2015, European journal of medicinal chemistry,
Silvia Galiano, and Oihana Erviti, and Silvia Pérez, and Antonio Moreno, and Laura Juanenea, and Ignacio Aldana, and Antonio Monge
February 1983, Journal of pharmaceutical sciences,
Silvia Galiano, and Oihana Erviti, and Silvia Pérez, and Antonio Moreno, and Laura Juanenea, and Ignacio Aldana, and Antonio Monge
April 2011, Journal of medicinal chemistry,
Copied contents to your clipboard!